Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Clinical Neuropharmacology|February 8, 2011
A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusionJerker Westin, Dag Nyholm, Sven Pålhagen, et al.
Artificial Intelligence in Medicine|April 19, 2017
Feasibility of spirography features for objective assessment of motor function in Parkinson's diseaseAleksander Sadikov, Vida Groznik, Martin Možina, et al.
Clinical Neuropharmacology|June 5, 2003
Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tabletsDag Nyholm, Håkan Askmark, Cecilia Gomes-Trolin, et al.
BMC Medical Ethics|October 19, 2022
Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview studyJennifer Drevin, Dag Nyholm, Håkan Widner, et al.
IEEE Journal of Biomedical and Health Informatics|August 19, 2015
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's DiseaseMevludin Memedi, Dag Nyholm, Anders Johansson, et al.
Sensors (Basel, Switzerland)|September 23, 2015
Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's DiseaseMevludin Memedi, Aleksander Sadikov, Vida Groznik, et al.
European Journal of Neurology|December 3, 2024
Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's diseaseMezin Öthman, Filip Bergquist, Per Odin, et al.
Movement Disorders Clinical Practice|June 26, 2024
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa InfusionFilip Bergquist, Mats Ehrnebo, Dag Nyholm, et al.
Clinical Neuropharmacology|May 3, 2012
Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteersDag Nyholm, Tommy Lewander, Cecilia Gomes-Trolin, et al.
Pageof 11